Dogwood Therapeutics Inc expected to post a loss of $1.41 a share - Earnings Preview

Dogwood Therapeutics

24/02/2025 14:16

* Dogwood Therapeutics Inc  DWTX.OQ   DWTX.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 26 (estimated) for the period ending December 31 2024
    * 
    * ​LSEG's mean analyst estimate for Dogwood Therapeutics Inc
is
for a loss of $1.41 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Dogwood
Therapeutics Inc is $25.00​, above​ its last closing price
of $5.36. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -1.10       -1.18      -2.05     Missed  -74.2
 Jun. 30 2024  -1.56       -1.58      -1.25     Beat    21
 Mar. 31 2024  -1.00       -1.00      -1.75     Missed  -75​
 Dec. 31 2023  -2.24       -2.25      -1.50     Beat    33.3
 ​​Sep.        -2.37       -2.37      -1.50     Beat    36.8
 30 2023                                                
 Jun. 30 2023  -1.75       -1.75      -2.00     Missed  -14.3​
 Mar. 31 2023  -5.00       -5.00      -2.00     Beat    60
 Dec. 31 2022  -3.87       -3.87      -2.75     Beat    29
 This summary was machine generated February 24 at 14:16 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)